You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Management of Ductal Carcinoma in Situ of the Breast

Version: 3 ID: 1-10 Jan 2018
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
W. Shelley, D. McCready, C. Holloway, M. Trudeau, S. Sinclair, Breast Cancer Disease Site Group

Patient Population

Women with DCIS.

Research Question(s)

  1. What is the optimal surgical management of ductal carcinoma in situ (DCIS) of the breast?
  2. Should breast irradiation be offered to women with DCIS, following breast-conserving surgery (defined as excision of the tumour with microscopically clear resection margins)? Are there patients who could be spared breast irradiation post–breast-conserving surgery for DCIS?
  3. What is the role of tamoxifen in the management of DCIS?
pdf download Summary (PDF) (263.86 KB)